*ST中珠(600568.SH):肖妃英擬增持不低於2%的公司股份
格隆匯 10 月 21日丨*ST中珠(600568.SH)公佈,2020年10月16日,受讓人肖妃英已披露《中珠醫療控股股份有限公司簡式權益變動報告書》(以下簡稱“《簡式權益變動報告書》”),擬以協議轉讓方式受讓20名交易對手所持中珠醫療控股股份有限公司(以下簡稱“中珠醫療”或“公司”)124,697,923股股份,佔公司總股本的比例約6.26%;同時,受讓人肖妃英在《簡式權益變動報告書》中披露在未來12個月內,擬選擇合適的時機繼續增加在公司中擁有的股份。截至本公告日,上述股份尚未完成過户。
受讓人肖妃英計劃結合自有資金安排以及市場情況,在與湯旭東等共計20名交易對手股份轉讓協議所涉公司124,697,923股股份完成過户登記之日起12個月內,通過上海證券交易所交易系統集中競價交易、大宗交易方式,以自有或自籌資金增持公司股份比例不低於2%,增持股份數量不低於39,857,394股;本次增持計劃未設定價格區間,肖妃英將基於對公司股票價格的合理判斷,並根據公司股票價格波動情況及資本市場整體趨勢,逐步實施增持計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.